Vancouver, British Columbia—An experimental model developed by Lynn R. Webster, MD, and his colleagues at PRA Health Sciences may help curb the frequency of life-threatening respiratory depression. Their model, which aims to document the respiratory effects of various drugs either alone or in combination, was piloted in an oxycodone model, with encouraging results.
“We have a crisis of unintentional overdose deaths,” said Dr. Webster, the vice president of Scientific Affairs of